Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up
- 30 April 1990
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 82 (1-2) , 85-95
- https://doi.org/10.1016/0021-9150(90)90147-b
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.Journal of Clinical Investigation, 1987
- Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1987
- The creatine kinase reference intervalJournal of the Neurological Sciences, 1985
- Influence of Combined Therapy with Mevinolin and Interruption of Bile-Acid Reabsorption on Low Density Lipoproteins in Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1985
- Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Colestipol and Probucol: Treatment of Primary and Familial Hypercholesterolemia and Amelioration of AtherosclerosisAnnals of Internal Medicine, 1982